Pursuant to the provisions of Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI LODR''), we wish to inform ....
Awaiting price reaction for this filing.
ADS Diagnostic Limited reported a sharp decline in FY25 performance. Revenue from operations fell to ₹1,599.96 lakhs from ₹2,396.20 lakhs in FY24, a drop of about 33%. Profit before tax nearly halved to ₹108.11 lakhs (vs ₹249.95 lakhs), and net profit after tax fell about 57% to ₹80.50 lakhs (vs ₹185.00 lakhs). Q4 FY25 was particularly weak, with revenue down 43% and PAT down nearly 79% versus Q4 FY24. EPS for the year stood at ₹3.67 versus ₹8.44 previously. Despite the profit decline, reserves grew to ₹376.92 lakhs from ₹212.55 lakhs, and operating cash flow remained positive at ₹77.73 lakhs. The statutory auditor V.N. Purohit & Co. issued an unmodified (clean) audit opinion with no qualifications.
A significant revenue and profit decline year-on-year is a negative signal for shareholders, reflecting weaker demand or business challenges. However, the clean audit opinion, positive operating cash flow, and growing reserves provide some reassurance about financial stability.